ACP Journal Club. Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia

Ann Intern Med. 2010 Mar 16;152(6):JC3-9. doi: 10.7326/0003-4819-152-6-201003160-02009.
No abstract available

Publication types

  • Comment